IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion

:  Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL‐17 expression in the skin and peripheral blood. Recent findings indicated that fila...

Full description

Saved in:
Bibliographic Details
Published inExperimental dermatology Vol. 21; no. 2; pp. 104 - 110
Main Authors Gutowska-Owsiak, Danuta, Schaupp, Anna L., Salimi, Maryam, Selvakumar, Tharini A., McPherson, Tess, Taylor, Stephen, Ogg, Graham S.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.02.2012
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
Abstract :  Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL‐17 expression in the skin and peripheral blood. Recent findings indicated that filaggrin is essential during barrier formation and its insufficiency underlies the pathogenesis of atopic eczema. Filaggrin downregulation has also been reported in psoriasis. It is clear that Th1/Th2 bias influences expression of the protein, but an analysis of the effects of interleukin‐17 (IL‐17) on the expression of the protein and profilaggrin‐processing enzymes has not yet been reported. In addition, the effect of the cytokine on components of functional epidermal barrier, tight junctions and adhesion/desmosomal proteins, has not been elucidated. Keratinocytes were exposed to interleukin‐17A, and microarray analysis was performed. Filaggrin protein level was assessed by western blot. We have observed a significant decrease in profilaggrin mRNA level in interleukin‐17A‐exposed cultures (P = 0.008). Expression of processing enzymes was also altered, indicating an indirect effect of the cytokine on filaggrin production/degradation. Moreover, expression of many genes involved in cellular adhesion was also decreased. A significant downregulation of filaggrin at the protein level was detected by western blot in immortal and primary keratinocytes. Gene ontology analysis indicated changes in keratinization, epidermal differentiation and formation of the cornified envelope. We conclude that IL‐17A downregulates the expression of filaggrin and genes important for cellular adhesion which could affect epidermal barrier formation. This effect potentially contributes to barrier dysfunction and could become a possible therapeutic target.
AbstractList :  Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL‐17 expression in the skin and peripheral blood. Recent findings indicated that filaggrin is essential during barrier formation and its insufficiency underlies the pathogenesis of atopic eczema. Filaggrin downregulation has also been reported in psoriasis. It is clear that Th1/Th2 bias influences expression of the protein, but an analysis of the effects of interleukin‐17 (IL‐17) on the expression of the protein and profilaggrin‐processing enzymes has not yet been reported. In addition, the effect of the cytokine on components of functional epidermal barrier, tight junctions and adhesion/desmosomal proteins, has not been elucidated. Keratinocytes were exposed to interleukin‐17A, and microarray analysis was performed. Filaggrin protein level was assessed by western blot. We have observed a significant decrease in profilaggrin mRNA level in interleukin‐17A‐exposed cultures (P = 0.008). Expression of processing enzymes was also altered, indicating an indirect effect of the cytokine on filaggrin production/degradation. Moreover, expression of many genes involved in cellular adhesion was also decreased. A significant downregulation of filaggrin at the protein level was detected by western blot in immortal and primary keratinocytes. Gene ontology analysis indicated changes in keratinization, epidermal differentiation and formation of the cornified envelope. We conclude that IL‐17A downregulates the expression of filaggrin and genes important for cellular adhesion which could affect epidermal barrier formation. This effect potentially contributes to barrier dysfunction and could become a possible therapeutic target.
Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL-17 expression in the skin and peripheral blood. Recent findings indicated that filaggrin is essential during barrier formation and its insufficiency underlies the pathogenesis of atopic eczema. Filaggrin downregulation has also been reported in psoriasis. It is clear that Th1/Th2 bias influences expression of the protein, but an analysis of the effects of interleukin-17 (IL-17) on the expression of the protein and profilaggrin-processing enzymes has not yet been reported. In addition, the effect of the cytokine on components of functional epidermal barrier, tight junctions and adhesion/desmosomal proteins, has not been elucidated. Keratinocytes were exposed to interleukin-17A, and microarray analysis was performed. Filaggrin protein level was assessed by western blot. We have observed a significant decrease in profilaggrin mRNA level in interleukin-17A-exposed cultures (P=0.008). Expression of processing enzymes was also altered, indicating an indirect effect of the cytokine on filaggrin production/degradation. Moreover, expression of many genes involved in cellular adhesion was also decreased. A significant downregulation of filaggrin at the protein level was detected by western blot in immortal and primary keratinocytes. Gene ontology analysis indicated changes in keratinization, epidermal differentiation and formation of the cornified envelope. We conclude that IL-17A downregulates the expression of filaggrin and genes important for cellular adhesion which could affect epidermal barrier formation. This effect potentially contributes to barrier dysfunction and could become a possible therapeutic target.
Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL‐17 expression in the skin and peripheral blood. Recent findings indicated that filaggrin is essential during barrier formation and its insufficiency underlies the pathogenesis of atopic eczema. Filaggrin downregulation has also been reported in psoriasis. It is clear that Th1/Th2 bias influences expression of the protein, but an analysis of the effects of interleukin‐17 (IL‐17) on the expression of the protein and profilaggrin‐processing enzymes has not yet been reported. In addition, the effect of the cytokine on components of functional epidermal barrier, tight junctions and adhesion/desmosomal proteins, has not been elucidated. Keratinocytes were exposed to interleukin‐17A, and microarray analysis was performed. Filaggrin protein level was assessed by western blot. We have observed a significant decrease in profilaggrin mRNA level in interleukin‐17A‐exposed cultures ( P  = 0.008). Expression of processing enzymes was also altered, indicating an indirect effect of the cytokine on filaggrin production/degradation. Moreover, expression of many genes involved in cellular adhesion was also decreased. A significant downregulation of filaggrin at the protein level was detected by western blot in immortal and primary keratinocytes. Gene ontology analysis indicated changes in keratinization, epidermal differentiation and formation of the cornified envelope. We conclude that IL‐17A downregulates the expression of filaggrin and genes important for cellular adhesion which could affect epidermal barrier formation. This effect potentially contributes to barrier dysfunction and could become a possible therapeutic target.
Author Schaupp, Anna L.
Gutowska-Owsiak, Danuta
McPherson, Tess
Salimi, Maryam
Taylor, Stephen
Ogg, Graham S.
Selvakumar, Tharini A.
Author_xml – sequence: 1
  givenname: Danuta
  surname: Gutowska-Owsiak
  fullname: Gutowska-Owsiak, Danuta
  organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK
– sequence: 2
  givenname: Anna L.
  surname: Schaupp
  fullname: Schaupp, Anna L.
  organization: Translational Gastroenterology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK
– sequence: 3
  givenname: Maryam
  surname: Salimi
  fullname: Salimi, Maryam
  organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK
– sequence: 4
  givenname: Tharini A.
  surname: Selvakumar
  fullname: Selvakumar, Tharini A.
  organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK
– sequence: 5
  givenname: Tess
  surname: McPherson
  fullname: McPherson, Tess
  organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK
– sequence: 6
  givenname: Stephen
  surname: Taylor
  fullname: Taylor, Stephen
  organization: Computational Biology Research Group, University of Oxford, John Radcliffe Hospital, Oxford, UK
– sequence: 7
  givenname: Graham S.
  surname: Ogg
  fullname: Ogg, Graham S.
  organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25579285$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22229441$$D View this record in MEDLINE/PubMed
BookMark eNqNkUFv0zAUxy00xLrBV0C-IHFJsB07Tg4c0DbGpAKXoSEuluM8d-5Su7NTtf32OLSUK-9iS_7933v6-QKd-eABIUxJSXN9WJa0JqQgNRMlI5SWhHLKyt0LNDs9nKEZaUld1JKIc3SR0pIQKispXqFzlqvlnM7QcDcvqMR92PoIi82gR0jYukEvFtF5rH2PtbVgxoSfIOrR-WD2I2DYrSOk5ILHweIF-BzTKQXjcoceb934iA0MQ-4Yse4fYUJfo5dWDwneHM9L9OPzzf3Vl2L-_fbu6tO8MIK2rKhAdy0XXBrObAPGEAENYxxYz1krhK11bzvBtJSWdz3IClra9Zm1NeetqS7R-0PfdQzPG0ijWrk0baM9hE1SVIqKS8oZyWhzQE0MKUWwah3dSse9okRNrtVSTUrVpFRNrtUf12qXo2-PUzbdCvpT8K_cDLw7AjoZPdiovXHpHyeEbFkjMvfxwG3dAPv_XkDd_LyebjlfHPIujbA75XV8UvX04erh261qfn1l9w_Ntaqr3yhSrD8
CitedBy_id crossref_primary_10_1002_jev2_12335
crossref_primary_10_1016_j_det_2017_02_006
crossref_primary_10_1007_s13770_023_00532_1
crossref_primary_10_1016_j_xcrm_2023_101340
crossref_primary_10_1002_iub_1405
crossref_primary_10_1111_all_14488
crossref_primary_10_4161_21688370_2014_974451
crossref_primary_10_1007_s40674_015_0019_2
crossref_primary_10_1007_s11882_012_0293_0
crossref_primary_10_1016_j_jaad_2013_12_036
crossref_primary_10_1177_1203475417722552
crossref_primary_10_2174_1871530319666191129120253
crossref_primary_10_1097_ACI_0000000000000306
crossref_primary_10_1111_cea_13697
crossref_primary_10_1111_ced_14384
crossref_primary_10_1097_JD9_0000000000000155
crossref_primary_10_3109_08916934_2016_1166214
crossref_primary_10_1038_s41423_023_00992_4
crossref_primary_10_2217_imt_2016_0128
crossref_primary_10_1016_j_anai_2019_10_005
crossref_primary_10_21518_ms2024_017
crossref_primary_10_3389_fimmu_2021_764384
crossref_primary_10_1016_j_semarthrit_2013_04_006
crossref_primary_10_1080_25785826_2019_1642727
crossref_primary_10_2147_CCID_S462797
crossref_primary_10_3389_fmed_2024_1335551
crossref_primary_10_1007_s12016_014_8415_1
crossref_primary_10_1007_s40259_014_0098_x
crossref_primary_10_1093_bjd_ljac039
crossref_primary_10_1016_j_yexcr_2017_09_004
crossref_primary_10_1016_S0151_9638_20_31082_6
crossref_primary_10_1111_1346_8138_15507
crossref_primary_10_1097_DAD_0000000000000378
crossref_primary_10_3390_jcm10245834
crossref_primary_10_1038_s41541_017_0014_8
crossref_primary_10_2147_DDDT_S240866
crossref_primary_10_1080_1744666X_2019_1564038
crossref_primary_10_1016_j_jphs_2021_09_006
crossref_primary_10_1111_bjd_14908
crossref_primary_10_1098_rsfs_2012_0090
crossref_primary_10_1111_vde_13125
crossref_primary_10_3390_jcm12041538
crossref_primary_10_3390_biomedicines10051183
crossref_primary_10_3892_ijmm_2015_2445
crossref_primary_10_1002_ptr_6061
crossref_primary_10_3390_ijms221910841
crossref_primary_10_1016_j_jddst_2024_105909
crossref_primary_10_1016_j_jaci_2016_02_008
crossref_primary_10_1016_j_bbamcr_2013_06_010
crossref_primary_10_1111_bjd_16487
crossref_primary_10_3390_ijms22115729
crossref_primary_10_1111_cpr_13441
crossref_primary_10_1111_exd_13808
crossref_primary_10_17816_dv607439
crossref_primary_10_1007_s00441_014_2096_1
crossref_primary_10_3390_ijms24097956
crossref_primary_10_1111_imm_12142
crossref_primary_10_3389_fimmu_2021_761890
crossref_primary_10_1038_s41598_017_15892_7
crossref_primary_10_1038_s41598_022_15393_2
crossref_primary_10_1016_j_dsi_2015_03_007
crossref_primary_10_1016_j_xjidi_2022_100131
crossref_primary_10_1111_j_1365_2133_2012_11099_x
crossref_primary_10_1016_j_jaci_2024_04_009
crossref_primary_10_3390_ijms14046720
crossref_primary_10_1016_j_anai_2017_09_055
crossref_primary_10_1080_14712598_2020_1729736
crossref_primary_10_1111_exd_12554
crossref_primary_10_3389_fmolb_2022_917077
crossref_primary_10_3389_fimmu_2020_594735
crossref_primary_10_1016_j_anai_2018_11_015
crossref_primary_10_1038_s41598_017_00670_2
crossref_primary_10_1016_j_dsi_2012_07_003
crossref_primary_10_1089_ped_2014_0482
crossref_primary_10_25208_vdv1286
crossref_primary_10_3892_mmr_2017_7689
crossref_primary_10_1080_13543784_2024_2347294
crossref_primary_10_1007_s40744_017_0084_0
crossref_primary_10_1016_j_cytogfr_2017_09_005
crossref_primary_10_1097_DAD_0000000000002418
crossref_primary_10_1016_j_intimp_2022_108795
crossref_primary_10_1016_j_jaci_2014_06_014
crossref_primary_10_1016_j_jaci_2014_04_021
crossref_primary_10_1111_ddg_12812
crossref_primary_10_1111_ced_12567
crossref_primary_10_1111_ddg_80_12812
crossref_primary_10_3390_ijms232113498
crossref_primary_10_3390_cells12242793
crossref_primary_10_1097_ACI_0b013e32835af232
crossref_primary_10_1371_journal_pone_0288347
crossref_primary_10_17816_dv108870
crossref_primary_10_1126_scitranslmed_aad6833
crossref_primary_10_1016_j_jaci_2019_07_013
crossref_primary_10_1111_imr_12545
crossref_primary_10_1007_s00424_016_1903_9
crossref_primary_10_1111_cea_13897
crossref_primary_10_15570_actaapa_2022_3
crossref_primary_10_4049_jimmunol_1602185
crossref_primary_10_1111_jdv_12753
crossref_primary_10_12677_ACM_2023_134740
crossref_primary_10_2336_nishinihonhifu_75_399
crossref_primary_10_15690_vsp_v18i5_2064
crossref_primary_10_1016_j_jaci_2018_02_040
crossref_primary_10_1080_09546634_2021_1967268
crossref_primary_10_1016_j_piel_2015_04_011
crossref_primary_10_1007_s10067_015_2961_7
crossref_primary_10_3390_ijms17020244
crossref_primary_10_3390_ijms19103086
crossref_primary_10_3390_ijms20174070
crossref_primary_10_4168_aard_2020_8_1_9
crossref_primary_10_1007_s40265_014_0219_3
crossref_primary_10_1111_jdv_13619
crossref_primary_10_1007_s13233_023_00236_4
crossref_primary_10_1134_S1022795414100123
crossref_primary_10_1007_s10067_016_3350_6
crossref_primary_10_3390_ijms23105318
crossref_primary_10_1016_j_jaci_2015_04_026
crossref_primary_10_1016_j_jaci_2018_10_032
crossref_primary_10_1016_j_lfs_2013_07_027
crossref_primary_10_1016_j_piel_2018_01_010
crossref_primary_10_25208_0042_4609_2019_95_1_59_76
crossref_primary_10_1097_ACI_0b013e328364e8f7
crossref_primary_10_1016_j_jid_2016_07_043
crossref_primary_10_1016_j_jaci_2012_12_668
crossref_primary_10_4168_aair_2018_10_3_207
crossref_primary_10_1080_00914037_2023_2299801
crossref_primary_10_15789_1563_0625_IRI_2138
crossref_primary_10_1097_DER_0000000000000143
crossref_primary_10_1016_j_jaci_2015_01_048
crossref_primary_10_1111_dth_12787
crossref_primary_10_1007_s11882_014_0433_9
crossref_primary_10_3390_ijms21186484
crossref_primary_10_3389_fphar_2022_1067051
crossref_primary_10_1371_journal_pone_0161759
crossref_primary_10_1016_j_jconrel_2016_08_007
crossref_primary_10_1111_exd_14425
crossref_primary_10_1002_ski2_99
crossref_primary_10_3389_fimmu_2018_01682
crossref_primary_10_1111_cea_12023
crossref_primary_10_1016_j_jid_2016_12_032
crossref_primary_10_3906_vet_1507_26
crossref_primary_10_1016_j_redox_2020_101530
crossref_primary_10_1038_s41590_018_0256_2
crossref_primary_10_23902_trkjnat_878417
crossref_primary_10_3390_healthcare8020070
crossref_primary_10_1016_j_jdermsci_2013_02_001
crossref_primary_10_3390_ijms21155382
crossref_primary_10_1016_j_cbi_2022_110122
crossref_primary_10_1007_s40259_021_00490_x
crossref_primary_10_1038_cdd_2017_56
crossref_primary_10_1111_1346_8138_15250
crossref_primary_10_1111_cod_12021
crossref_primary_10_21518_2079_701X_2022_16_3_130_136
crossref_primary_10_3389_fmed_2017_00119
crossref_primary_10_1111_cei_13449
crossref_primary_10_1016_j_det_2018_12_007
crossref_primary_10_1016_j_jid_2019_04_024
crossref_primary_10_1016_j_biopha_2021_112569
crossref_primary_10_1016_j_biopha_2020_111065
crossref_primary_10_1007_s12272_021_01305_x
crossref_primary_10_1016_j_jid_2020_07_006
crossref_primary_10_1016_j_jaci_2017_01_011
crossref_primary_10_1016_j_jaci_2021_07_003
crossref_primary_10_3390_jcm10112506
Cites_doi 10.1111/j.1365-2133.2006.07642.x
10.1016/j.jaci.2009.05.042
10.1016/j.jaad.2010.09.714
10.1038/ng1767
10.1038/jid.2008.280
10.1159/000314366
10.1111/1523-1747.ep12466185
10.1038/sj.jid.5700720
10.1084/jem.20071094
10.1038/jid.2008.29
10.1093/bioinformatics/btn224
10.1016/j.jaci.2007.04.031
10.1128/IAI.00958-10
10.1038/jid.2008.413
10.1038/sj.jid.5701213
10.1111/j.1398-9995.2010.02493.x
10.4049/jimmunol.179.7.4313
10.1111/j.1365-2133.2010.10068.x
10.1038/jid.2008.283
10.1111/j.1365-2133.2005.06352.x
10.1038/jid.2010.277
10.1046/j.0022-202x.2001.01493.x
10.1046/j.1523-1747.1998.00347.x
10.1038/sj.jid.5700817
10.1186/1471-2105-10-48
10.1067/mai.2000.110159
10.1002/eji.200939473
10.1111/j.1398-9995.1997.tb02158.x
10.1111/j.0022-202X.2005.23762.x
10.1111/j.1365-2133.2010.09866.x
10.1016/0167-4838(83)90336-9
10.1016/j.jaci.2008.10.031
10.1111/j.0906-6705.2005.00338.x
10.1111/j.1600-0625.2008.00786.x
10.1111/j.1600-0625.2009.00902.x
10.1038/jid.2009.399
10.1074/jbc.M409026200
10.1136/bmj.b2433
10.2353/ajpath.2009.080973
10.1038/sj.jid.5700582
10.1111/j.1600-0625.2006.00539.x
10.1016/j.jaci.2009.12.934
10.1016/j.jaci.2007.12.1161
10.1046/j.1365-2133.1999.03038.x
10.1097/01.LAB.0000036874.83540.2B
10.1046/j.1523-1747.2000.00041.x
10.1016/j.jdermsci.2008.12.011
10.1016/j.jaci.2009.07.040
10.1016/j.jaci.2011.01.031
10.1189/JLB.0109046
10.1097/ACI.0b013e3282ef869e
10.1038/jid.2010.175
10.1080/00015550050500077
10.1016/j.arcmed.2005.07.003
10.4049/jimmunol.181.10.7420
10.2174/156652408785160952
10.2353/ajpath.2007.061067
10.1016/j.bbamem.2008.08.027
10.2202/1544-6115.1027
10.1111/j.1600-0625.2006.00478.x
10.1111/j.1365-2133.2005.06989.x
10.1016/j.jaci.2010.10.018
10.1007/s12016-007-0042-7
10.1159/000250218
10.1038/jid.2011.24
10.1111/j.1365-2133.2009.09582.x
10.1111/j.0022-202X.2005.23935.x
10.1002/path.2200
10.1073/pnas.0706942104
10.1016/j.jaci.2003.08.049
10.1016/j.jaci.2009.09.031
10.1016/j.jaci.2009.03.041
10.1007/s004030100221
10.1111/j.1346-8138.2004.tb00672.x
10.1038/jid.2008.111
10.1111/j.1600-0625.2011.01280.x
10.1038/jid.2010.307
10.1067/mai.2003.1414
ContentType Journal Article
Copyright 2011 John Wiley & Sons A/S
2015 INIST-CNRS
2011 John Wiley & Sons A/S.
Copyright_xml – notice: 2011 John Wiley & Sons A/S
– notice: 2015 INIST-CNRS
– notice: 2011 John Wiley & Sons A/S.
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
8FD
FR3
P64
RC3
DOI 10.1111/j.1600-0625.2011.01412.x
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList
Genetics Abstracts
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0625
EndPage 110
ExternalDocumentID 10_1111_j_1600_0625_2011_01412_x
22229441
25579285
EXD1412
ark_67375_WNG_8ZM2TW8D_6
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Medical Research Council
  grantid: MC_U137881017
– fundername: Medical Research Council
  grantid: G0701693
– fundername: Medical Research Council
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29G
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAJUZ
AAVGM
ABCVL
ABHUG
ABPTK
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
8FD
FR3
P64
RC3
ID FETCH-LOGICAL-c5192-3eab94547c42f8ecc05e8224e2d42955f6adfb52a77f4bde73e91bd2f8f6449c3
IEDL.DBID DR2
ISSN 0906-6705
IngestDate Fri Aug 16 12:14:28 EDT 2024
Fri Aug 23 00:33:13 EDT 2024
Sat Sep 28 08:35:27 EDT 2024
Tue Jan 23 04:49:25 EST 2024
Sat Aug 24 00:53:50 EDT 2024
Wed Oct 30 09:53:32 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Allergy
Immunopathology
Skin disease
Dermatology
keratinocytes
Adhesion
atopic eczema
Interleukin 17
Atopy
Eczema
IL-17
Keratinocyte
epidermal barrier
filaggrin
Language English
License CC BY 4.0
2011 John Wiley & Sons A/S.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5192-3eab94547c42f8ecc05e8224e2d42955f6adfb52a77f4bde73e91bd2f8f6449c3
Notes istex:4423AED045EC8FC3E2950D3B9EE5B367A525DD79
ark:/67375/WNG-8ZM2TW8D-6
ArticleID:EXD1412
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1600-0625.2011.01412.x
PMID 22229441
PQID 1753471420
PQPubID 23462
PageCount 7
ParticipantIDs proquest_miscellaneous_1753471420
crossref_primary_10_1111_j_1600_0625_2011_01412_x
pubmed_primary_22229441
pascalfrancis_primary_25579285
wiley_primary_10_1111_j_1600_0625_2011_01412_x_EXD1412
istex_primary_ark_67375_WNG_8ZM2TW8D_6
PublicationCentury 2000
PublicationDate February 2012
PublicationDateYYYYMMDD 2012-02-01
PublicationDate_xml – month: 02
  year: 2012
  text: February 2012
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: Denmark
PublicationTitle Experimental dermatology
PublicationTitleAlternate Exp Dermatol
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Blackwell
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
References Capaldo C T, Nusrat A. Biochim Biophys Acta 2009: 1788: 864-871 [Review].
Di Cesare A, Di Meglio P, Nestle F O. J Invest Dermatol 2008: 128: 2569-2571.
Milovanovic M, Drozdenko G, Weise C et al. J Invest Dermatol 2010: 130: 2621-2628.
Harris T J, Grosso J F, Yen H R et al. J Immunol 2007: 7: 4313-4317.
Yoshida Y, Morita K, Mizoguchi A et al. Arch Dermatol Res 2001: 293: 239-244.
Lynley A M, Dale B A. Biochim Biophys Acta 1983: 1: 28-35.
van den Oord R A, Sheikh A. BMJ 2009: 339: b2433.
Ma H L, Liang S, Li J et al. J Clin Invest 2008: 118: 597-607.
van Beelen A J, Teunissen M B, Kapsenberg M L et al. Curr Opin Allergy Clin Immunol 2007: 7: 374-381.
Dai Y S. Clin Rev Allergy Immunol 2007: 33: 157-166.
Nograles K E, Suarez-Farinas M, Shemer A et al. J Allergy Clin Immunol 2010: 125: 744-746, 746 e1-e2.
Olaiwan A, Chandesris M O, Fraitag S et al. J Am Acad Dermatol 2011: 65: 1167-1172.
He R, Kim H Y, Yoon J et al. J Allergy Clin Immunol 2009: 124: 761-770, 770 e1.
Beck L A, Leung D Y. J Allergy Clin Immunol 2000: 106 (Suppl 5): S258-S263 [review].
Du P, Kibbe W A, Lin S M. Bioinformatics 2008: 24: 1547-1548.
Koga C, Kabashima K, Shiraishi N et al. J Invest Dermatol 2008: 128: 2625-2630.
Mee J B, Johnson C M, Morar N et al. Am J Pathol 2007: 171: 32-42.
Negosanti M, Fanti P A, Gasponi A et al. Dermatologica 1981: 163: 474-475.
Noh M, Yeo H, Ko J et al. Exp Dermatol 2010: 19: 355-362.
Palmer C N, Irvine A D, Terron-Kwiatkowski A et al. Nat Genet 2006: 38: 441-446.
Flohr C, England K, Radulovic S et al. Br J Dermatol 2010: 163: 1333-1336.
Ovcina-Kurtovic N, Kasumagic-Halilovic E. Med Arh 2010: 64: 28-29.
Watson R E, Poddar R, Walker J M et al. J Pathol 2007: 212: 450-458.
Kotsimbos T C, Ernst P, Hamid Q A. Proc Assoc Am Physicians 1996: 108: 368-373.
Kagami S, Rizzo H L, Lee J J et al. J Invest Dermatol 2010: 130: 1373-1383.
Itoh K, Kawasaki S, Kawamoto S et al. Exp Dermatol 2005: 14: 667-674.
Smyth G K. Stat Appl Genet Mol Biol 2004: 3: Article3.
Takaishi M, Makino T, Morohashi M et al. J Biol Chem 2005: 6: 4696-4703.
Horikoshi T, Igarashi S, Uchiwa H et al. Br J Dermatol 1999: 141: 453-459.
Jensen J M, Proksch E. G Ital Dermatol Venereol 2009: 144: 689-700.
Guttman-Yassky E, Suarez-Farinas M, Chiricozzi A et al. J Allergy Clin Immunol 2009: 124: 1235-1244.
Niebuhr M, Gathmann M, Scharonow H et al. Infect Immun 2011: 79: 1615-1622 [Epub 2011 Jan 18].
Gupta J, Grube E, Ericksen M B et al. J Allergy Clin Immunol 2008: 121: 725-730, 730 e2.
Chung E, Cook P W, Parkos C A et al. J Invest Dermatol 2005: 124: 1134-1140.
Zhang H, Guo Y, Wang W et al. Allergy 2011: 66: 420-427.
Niebuhr M, Gathmann M, Scharonow H et al. Infect Immun 2011: 79: 1615-1622.
Guttman-Yassky E, Lowes M A, Fuentes-Duculan J et al. J Immunol 2008: 10: 7420-7427.
Iizuka H, Takahashi H, Honma M et al. J Dermatol 2004: 31: 271-276.
Akiyama M. Br J Dermatol 2010: 162: 472-477.
Howell M D, Kim B E, Gao P et al. J Allergy Clin Immunol 2007: 120: 150-155.
McPherson T, Sherman V J, Aslam A et al. Br J Dermatol 2010: 3: 544-549.
He R, Oyoshi M K, Jin H et al. Proc Natl Acad Sci U S A 2007: 40: 15817-15822.
Nomura I, Gao B, Boguniewicz M et al. J Allergy Clin Immunol 2003: 112: 1195-1202.
Albanesi C, Scarponi C, Cavani A et al. J Invest Dermatol 2000: 115: 81-87.
Nograles K E, Zaba L C, Shemer A et al. J Allergy Clin Immunol 2009: 123: 1244-1252, 1252 e2.
Nemoto-Hasebe I, Akiyama M, Nomura T et al. J Invest Dermatol 2009: 129: 682-689.
Barnes P J. Curr Mol Med 2008: 8: 330-334.
Peltonen S, Riehokainen J, Pummi K et al. Br J Dermatol 2007: 156: 466-472.
Kim B E, Howell M D, Guttman E et al. J Invest Dermatol 2011: 131: 1272-1279.
Kirschner N, Poetzl C, von den Driesch P et al. Am J Pathol 2009: 175: 1095-1106.
Zhao Y, Terron-Kwiatkowski A, Liao H et al. J Invest Dermatol 2007: 127: 1878-1882.
Gabrielsson S, Paulie S, Roquet A et al. Allergy 1997: 52: 860-865.
Bottema R W, Nolte I M, Howard T D et al. Int Arch Allergy Immunol 2010: 153: 259-267.
Dale B A, Gown A M, Fleckman P et al. J Invest Dermatol 1987: 88: 306-313.
Teunissen M B, Koomen C W, de Waal Malefyt R et al. J Invest Dermatol 1998: 111: 645-649.
Hvid M, Vestergaard C, Kemp K et al. J Invest Dermatol 2011: 131: 150-157.
Wang L F, Chiu H C, Hsu C J et al. J Dermatol Sci 2009: 54: 192-197.
Huffmeier U, Traupe H, Oji V et al. J Invest Dermatol 2007: 127: 1367-1370.
Proksch E, Brandner J M, Jensen J M. Exp Dermatol 2008: 17: 1063-1072.
Ortega C, Fernandez A S, Carrillo J M et al. J Leukoc Biol 2009: 86: 435-443.
Pigatto P D. Acta Derm Venereol Suppl (Stockh) 2000: 211: 19-20.
Toda M, Leung D Y, Molet S et al. J Allergy Clin Immunol 2003: 111: 875-881.
de Jongh C M, Jakasa I, Verberk M M et al. Br J Dermatol 2006: 154: 651-657.
Yuki T, Haratake A, Koishikawa H et al. Exp Dermatol 2007: 16: 324-330.
Kezic S, Kemperman P M, Koster E S et al. J Invest Dermatol 2008: 128: 2117-2119.
Jakasa I, Verberk M M, Esposito M et al. J Invest Dermatol 2007: 127: 129-134.
de Jongh G J, Zeeuwen P L, Kucharekova M et al. J Invest Dermatol 2005: 125: 1163-1173.
Jakasa I, Verberk M M, Bunge A L et al. Exp Dermatol 2006: 15: 801-807.
Hvid M, Johansen C, Deleuran B et al. Exp Dermatol 2011: 20: 633-636.
Oyoshi M K, Murphy G F, Geha R S. J Allergy Clin Immunol 2009: 124: 485-493, 493 e1.
Hata M, Tokura Y, Takigawa M et al. Lab Invest 2002: 82: 1451-1461.
Brown S J, Asai Y, Cordell H J et al. J Allergy Clin Immunol 2011: 127: 661-667.
Pummi K, Malminen M, Aho H et al. J Invest Dermat 2001: 117: 1050-1058.
De Benedetto A, Rafaels N M, McGirt L Y et al. J Allergy Clin Immunol 2011: 127: 773-786, 786 e7.
Sugiura H, Ebise H, Tazawa T et al. Br J Dermatol 2005: 152: 146-149.
Eyerich K, Pennino D, Scarponi C et al. J Allergy Clin Immunol 2009: 123: 59-66, 66 e4.
Eden E, Navon R, Steinfeld I et al. BMC Bioinformatics 2009: 10: 48.
Lemini-Lopez A, Flores-Romo L, Arevalo-Lopez A et al. Arch Med Res 2006: 37: 36-44.
Jakasa I, Koster E S, Calkoen F et al. J Invest Dermatol 2011: 131: 540-542.
Lowes M A, Kikuchi T, Fuentes-Duculan J et al. J Invest Dermatol 2008: 128: 1207-1211.
Tohyama M, Hanakawa Y, Shirakata Y et al. Eur J Immunol 2009: 39: 2779-2788.
Zaba L C, Cardinale I, Gilleaudeau P et al. J Exp Med 2007: 13: 3183-3194.
Fedi A M, Leoncini P, Farella V et al. G Ital Dermatol Venereol 1989: 124: 141-145.
Brown S J, McLean W H. J Invest Dermatol 2009: 129: 543-552.
2009; 86
2010; 19
1983; 1
2006; 38
2006; 37
2004; 3
2008; 8
2000; 211
1998; 111
2007; 33
2003; 112
1996; 108
2003; 111
2011; 127
1987; 88
2007; 212
2004; 31
2010; 64
2001; 293
2009; 10
2009; 54
1997; 52
2007; 171
2011; 20
2011; 66
2009; 123
2008; 118
2010; 153
2008; 24
2009; 124
2007; 7
2011; 65
2009; 129
2010; 3
2009; 1788
2007; 127
2005; 152
2000; 115
2010; 125
1981; 163
2006; 15
2008; 17
2007; 120
2010; 163
2006; 154
2008; 128
1999; 141
2008; 10
2011; 79
2010; 162
2002; 82
2009; 175
2009; 339
2008; 121
2007; 13
2011; 131
2007; 16
2007; 156
1989; 124
2005; 124
2000; 106
2005; 125
2009; 144
2010; 130
2005; 6
2007; 40
2001; 117
2009; 39
2005; 14
e_1_2_7_5_2
e_1_2_7_3_2
e_1_2_7_9_2
e_1_2_7_7_2
e_1_2_7_19_2
e_1_2_7_83_2
e_1_2_7_15_2
e_1_2_7_60_2
e_1_2_7_81_2
e_1_2_7_13_2
e_1_2_7_41_2
e_1_2_7_62_2
e_1_2_7_11_2
e_1_2_7_43_2
e_1_2_7_64_2
e_1_2_7_85_2
e_1_2_7_45_2
e_1_2_7_66_2
e_1_2_7_47_2
e_1_2_7_68_2
e_1_2_7_26_2
e_1_2_7_49_2
Fedi A M (e_1_2_7_79_2) 1989; 124
Jensen J M (e_1_2_7_17_2) 2009; 144
e_1_2_7_50_2
e_1_2_7_25_2
e_1_2_7_52_2
e_1_2_7_75_2
e_1_2_7_23_2
e_1_2_7_31_2
e_1_2_7_54_2
e_1_2_7_73_2
e_1_2_7_21_2
e_1_2_7_33_2
e_1_2_7_56_2
e_1_2_7_35_2
e_1_2_7_58_2
e_1_2_7_77_2
e_1_2_7_37_2
e_1_2_7_39_2
e_1_2_7_4_2
e_1_2_7_2_2
e_1_2_7_8_2
e_1_2_7_6_2
e_1_2_7_18_2
e_1_2_7_82_2
e_1_2_7_16_2
e_1_2_7_61_2
e_1_2_7_80_2
e_1_2_7_14_2
e_1_2_7_40_2
e_1_2_7_63_2
e_1_2_7_12_2
e_1_2_7_42_2
e_1_2_7_65_2
e_1_2_7_10_2
e_1_2_7_44_2
e_1_2_7_67_2
e_1_2_7_46_2
e_1_2_7_69_2
e_1_2_7_48_2
e_1_2_7_27_2
e_1_2_7_29_2
e_1_2_7_72_2
Ovcina‐Kurtovic N (e_1_2_7_84_2) 2010; 64
e_1_2_7_70_2
e_1_2_7_24_2
e_1_2_7_30_2
e_1_2_7_51_2
e_1_2_7_76_2
e_1_2_7_22_2
e_1_2_7_32_2
e_1_2_7_53_2
e_1_2_7_74_2
e_1_2_7_20_2
e_1_2_7_34_2
e_1_2_7_55_2
e_1_2_7_36_2
e_1_2_7_57_2
Ma H L (e_1_2_7_71_2) 2008; 118
e_1_2_7_78_2
e_1_2_7_38_2
e_1_2_7_59_2
Kotsimbos T C (e_1_2_7_28_2) 1996; 108
References_xml – volume: 108
  start-page: 368
  year: 1996
  end-page: 373
  publication-title: Proc Assoc Am Physicians
– volume: 293
  start-page: 239
  year: 2001
  end-page: 244
  publication-title: Arch Dermatol Res
– volume: 15
  start-page: 801
  year: 2006
  end-page: 807
  publication-title: Exp Dermatol
– volume: 128
  start-page: 2569
  year: 2008
  end-page: 2571
  publication-title: J Invest Dermatol
– volume: 10
  start-page: 48
  year: 2009
  publication-title: BMC Bioinformatics
– volume: 121
  start-page: 725
  year: 2008
  end-page: 730
  publication-title: J Allergy Clin Immunol
– volume: 8
  start-page: 330
  year: 2008
  end-page: 334
  publication-title: Curr Mol Med
– volume: 124
  start-page: 1235
  year: 2009
  end-page: 1244
  publication-title: J Allergy Clin Immunol
– volume: 163
  start-page: 1333
  year: 2010
  end-page: 1336
  publication-title: Br J Dermatol
– volume: 129
  start-page: 682
  year: 2009
  end-page: 689
  publication-title: J Invest Dermatol
– volume: 127
  start-page: 1367
  year: 2007
  end-page: 1370
  publication-title: J Invest Dermatol
– volume: 3
  start-page: 544
  year: 2010
  end-page: 549
  publication-title: Br J Dermatol
– volume: 111
  start-page: 875
  year: 2003
  end-page: 881
  publication-title: J Allergy Clin Immunol
– volume: 130
  start-page: 1373
  year: 2010
  end-page: 1383
  publication-title: J Invest Dermatol
– volume: 40
  start-page: 15817
  year: 2007
  end-page: 15822
  publication-title: Proc Natl Acad Sci U S A
– volume: 127
  start-page: 661
  year: 2011
  end-page: 667
  publication-title: J Allergy Clin Immunol
– volume: 125
  start-page: 1163
  year: 2005
  end-page: 1173
  publication-title: J Invest Dermatol
– volume: 65
  start-page: 1167
  year: 2011
  end-page: 1172
  publication-title: J Am Acad Dermatol
– volume: 64
  start-page: 28
  year: 2010
  end-page: 29
  publication-title: Med Arh
– volume: 128
  start-page: 1207
  year: 2008
  end-page: 1211
  publication-title: J Invest Dermatol
– volume: 163
  start-page: 474
  year: 1981
  end-page: 475
  publication-title: Dermatologica
– volume: 7
  start-page: 4313
  year: 2007
  end-page: 4317
  publication-title: J Immunol
– volume: 118
  start-page: 597
  year: 2008
  end-page: 607
  publication-title: J Clin Invest
– volume: 124
  start-page: 761
  year: 2009
  end-page: 770
  publication-title: J Allergy Clin Immunol
– volume: 117
  start-page: 1050
  year: 2001
  end-page: 1058
  publication-title: J Invest Dermat
– volume: 212
  start-page: 450
  year: 2007
  end-page: 458
  publication-title: J Pathol
– volume: 127
  start-page: 129
  year: 2007
  end-page: 134
  publication-title: J Invest Dermatol
– volume: 16
  start-page: 324
  year: 2007
  end-page: 330
  publication-title: Exp Dermatol
– volume: 123
  start-page: 59
  year: 2009
  end-page: 66
  publication-title: J Allergy Clin Immunol
– volume: 141
  start-page: 453
  year: 1999
  end-page: 459
  publication-title: Br J Dermatol
– volume: 3
  start-page: Article3
  year: 2004
  publication-title: Stat Appl Genet Mol Biol
– volume: 106
  start-page: S258
  issue: Suppl 5
  year: 2000
  end-page: S263
  publication-title: J Allergy Clin Immunol
– volume: 127
  start-page: 1878
  year: 2007
  end-page: 1882
  publication-title: J Invest Dermatol
– volume: 131
  start-page: 540
  year: 2011
  end-page: 542
  publication-title: J Invest Dermatol
– volume: 131
  start-page: 1272
  year: 2011
  end-page: 1279
  publication-title: J Invest Dermatol
– volume: 162
  start-page: 472
  year: 2010
  end-page: 477
  publication-title: Br J Dermatol
– volume: 154
  start-page: 651
  year: 2006
  end-page: 657
  publication-title: Br J Dermatol
– volume: 120
  start-page: 150
  year: 2007
  end-page: 155
  publication-title: J Allergy Clin Immunol
– volume: 128
  start-page: 2625
  year: 2008
  end-page: 2630
  publication-title: J Invest Dermatol
– volume: 124
  start-page: 485
  year: 2009
  end-page: 493
  publication-title: J Allergy Clin Immunol
– volume: 13
  start-page: 3183
  year: 2007
  end-page: 3194
  publication-title: J Exp Med
– volume: 82
  start-page: 1451
  year: 2002
  end-page: 1461
  publication-title: Lab Invest
– volume: 6
  start-page: 4696
  year: 2005
  end-page: 4703
  publication-title: J Biol Chem
– volume: 171
  start-page: 32
  year: 2007
  end-page: 42
  publication-title: Am J Pathol
– volume: 66
  start-page: 420
  year: 2011
  end-page: 427
  publication-title: Allergy
– volume: 124
  start-page: 141
  year: 1989
  end-page: 145
  publication-title: G Ital Dermatol Venereol
– volume: 128
  start-page: 2117
  year: 2008
  end-page: 2119
  publication-title: J Invest Dermatol
– volume: 129
  start-page: 543
  year: 2009
  end-page: 552
  publication-title: J Invest Dermatol
– volume: 127
  start-page: 773
  year: 2011
  end-page: 786
  publication-title: J Allergy Clin Immunol
– volume: 131
  start-page: 150
  year: 2011
  end-page: 157
  publication-title: J Invest Dermatol
– volume: 20
  start-page: 633
  year: 2011
  end-page: 636
  publication-title: Exp Dermatol
– volume: 7
  start-page: 374
  year: 2007
  end-page: 381
  publication-title: Curr Opin Allergy Clin Immunol
– volume: 144
  start-page: 689
  year: 2009
  end-page: 700
  publication-title: G Ital Dermatol Venereol
– volume: 39
  start-page: 2779
  year: 2009
  end-page: 2788
  publication-title: Eur J Immunol
– volume: 1
  start-page: 28
  year: 1983
  end-page: 35
  publication-title: Biochim Biophys Acta
– volume: 339
  start-page: b2433
  year: 2009
  publication-title: BMJ
– volume: 1788
  start-page: 864
  year: 2009
  end-page: 871
  publication-title: Biochim Biophys Acta
– volume: 152
  start-page: 146
  year: 2005
  end-page: 149
  publication-title: Br J Dermatol
– volume: 153
  start-page: 259
  year: 2010
  end-page: 267
  publication-title: Int Arch Allergy Immunol
– volume: 24
  start-page: 1547
  year: 2008
  end-page: 1548
  publication-title: Bioinformatics
– volume: 38
  start-page: 441
  year: 2006
  end-page: 446
  publication-title: Nat Genet
– volume: 156
  start-page: 466
  year: 2007
  end-page: 472
  publication-title: Br J Dermatol
– volume: 14
  start-page: 667
  year: 2005
  end-page: 674
  publication-title: Exp Dermatol
– volume: 130
  start-page: 2621
  year: 2010
  end-page: 2628
  publication-title: J Invest Dermatol
– volume: 124
  start-page: 1134
  year: 2005
  end-page: 1140
  publication-title: J Invest Dermatol
– volume: 88
  start-page: 306
  year: 1987
  end-page: 313
  publication-title: J Invest Dermatol
– volume: 17
  start-page: 1063
  year: 2008
  end-page: 1072
  publication-title: Exp Dermatol
– volume: 112
  start-page: 1195
  year: 2003
  end-page: 1202
  publication-title: J Allergy Clin Immunol
– volume: 37
  start-page: 36
  year: 2006
  end-page: 44
  publication-title: Arch Med Res
– volume: 54
  start-page: 192
  year: 2009
  end-page: 197
  publication-title: J Dermatol Sci
– volume: 33
  start-page: 157
  year: 2007
  end-page: 166
  publication-title: Clin Rev Allergy Immunol
– volume: 86
  start-page: 435
  year: 2009
  end-page: 443
  publication-title: J Leukoc Biol
– volume: 123
  start-page: 1244
  year: 2009
  end-page: 1252
  publication-title: J Allergy Clin Immunol
– volume: 31
  start-page: 271
  year: 2004
  end-page: 276
  publication-title: J Dermatol
– volume: 115
  start-page: 81
  year: 2000
  end-page: 87
  publication-title: J Invest Dermatol
– volume: 19
  start-page: 355
  year: 2010
  end-page: 362
  publication-title: Exp Dermatol
– volume: 211
  start-page: 19
  year: 2000
  end-page: 20
  publication-title: Acta Derm Venereol Suppl (Stockh)
– volume: 79
  start-page: 1615
  year: 2011
  end-page: 1622
  publication-title: Infect Immun
– volume: 111
  start-page: 645
  year: 1998
  end-page: 649
  publication-title: J Invest Dermatol
– volume: 10
  start-page: 7420
  year: 2008
  end-page: 7427
  publication-title: J Immunol
– volume: 52
  start-page: 860
  year: 1997
  end-page: 865
  publication-title: Allergy
– volume: 175
  start-page: 1095
  year: 2009
  end-page: 1106
  publication-title: Am J Pathol
– volume: 125
  start-page: 744
  year: 2010
  end-page: 746
  publication-title: J Allergy Clin Immunol
– ident: e_1_2_7_33_2
  doi: 10.1111/j.1365-2133.2006.07642.x
– ident: e_1_2_7_70_2
  doi: 10.1016/j.jaci.2009.05.042
– ident: e_1_2_7_78_2
  doi: 10.1016/j.jaad.2010.09.714
– ident: e_1_2_7_2_2
  doi: 10.1038/ng1767
– ident: e_1_2_7_10_2
  doi: 10.1038/jid.2008.280
– ident: e_1_2_7_26_2
  doi: 10.1159/000314366
– ident: e_1_2_7_53_2
  doi: 10.1111/1523-1747.ep12466185
– ident: e_1_2_7_80_2
  doi: 10.1038/sj.jid.5700720
– ident: e_1_2_7_56_2
  doi: 10.1084/jem.20071094
– volume: 64
  start-page: 28
  year: 2010
  ident: e_1_2_7_84_2
  publication-title: Med Arh
  contributor:
    fullname: Ovcina‐Kurtovic N
– ident: e_1_2_7_6_2
  doi: 10.1038/jid.2008.29
– ident: e_1_2_7_47_2
  doi: 10.1093/bioinformatics/btn224
– volume: 124
  start-page: 141
  year: 1989
  ident: e_1_2_7_79_2
  publication-title: G Ital Dermatol Venereol
  contributor:
    fullname: Fedi A M
– ident: e_1_2_7_23_2
  doi: 10.1016/j.jaci.2007.04.031
– ident: e_1_2_7_65_2
  doi: 10.1128/IAI.00958-10
– ident: e_1_2_7_8_2
  doi: 10.1038/jid.2008.413
– ident: e_1_2_7_40_2
  doi: 10.1038/sj.jid.5701213
– ident: e_1_2_7_4_2
  doi: 10.1111/j.1398-9995.2010.02493.x
– ident: e_1_2_7_77_2
  doi: 10.4049/jimmunol.179.7.4313
– ident: e_1_2_7_3_2
  doi: 10.1111/j.1365-2133.2010.10068.x
– ident: e_1_2_7_46_2
  doi: 10.1038/jid.2008.283
– ident: e_1_2_7_59_2
  doi: 10.1111/j.1365-2133.2005.06352.x
– ident: e_1_2_7_75_2
  doi: 10.1128/IAI.00958-10
– ident: e_1_2_7_67_2
  doi: 10.1038/jid.2010.277
– ident: e_1_2_7_34_2
  doi: 10.1046/j.0022-202x.2001.01493.x
– ident: e_1_2_7_55_2
  doi: 10.1046/j.1523-1747.1998.00347.x
– ident: e_1_2_7_82_2
  doi: 10.1038/sj.jid.5700817
– ident: e_1_2_7_49_2
  doi: 10.1186/1471-2105-10-48
– ident: e_1_2_7_19_2
  doi: 10.1067/mai.2000.110159
– ident: e_1_2_7_57_2
  doi: 10.1002/eji.200939473
– ident: e_1_2_7_27_2
  doi: 10.1111/j.1398-9995.1997.tb02158.x
– volume: 108
  start-page: 368
  year: 1996
  ident: e_1_2_7_28_2
  publication-title: Proc Assoc Am Physicians
  contributor:
    fullname: Kotsimbos T C
– ident: e_1_2_7_30_2
  doi: 10.1111/j.0022-202X.2005.23762.x
– ident: e_1_2_7_21_2
  doi: 10.1111/j.1365-2133.2010.09866.x
– ident: e_1_2_7_5_2
  doi: 10.1016/0167-4838(83)90336-9
– ident: e_1_2_7_39_2
  doi: 10.1016/j.jaci.2008.10.031
– ident: e_1_2_7_69_2
  doi: 10.1111/j.0906-6705.2005.00338.x
– ident: e_1_2_7_18_2
  doi: 10.1111/j.1600-0625.2008.00786.x
– ident: e_1_2_7_68_2
  doi: 10.1111/j.1600-0625.2009.00902.x
– ident: e_1_2_7_43_2
  doi: 10.1038/jid.2009.399
– ident: e_1_2_7_81_2
  doi: 10.1074/jbc.M409026200
– ident: e_1_2_7_9_2
  doi: 10.1136/bmj.b2433
– ident: e_1_2_7_31_2
  doi: 10.2353/ajpath.2009.080973
– ident: e_1_2_7_16_2
  doi: 10.1038/sj.jid.5700582
– volume: 144
  start-page: 689
  year: 2009
  ident: e_1_2_7_17_2
  publication-title: G Ital Dermatol Venereol
  contributor:
    fullname: Jensen J M
– ident: e_1_2_7_51_2
  doi: 10.1111/j.1600-0625.2006.00539.x
– ident: e_1_2_7_58_2
  doi: 10.1016/j.jaci.2009.12.934
– ident: e_1_2_7_13_2
  doi: 10.1016/j.jaci.2007.12.1161
– ident: e_1_2_7_50_2
  doi: 10.1046/j.1365-2133.1999.03038.x
– ident: e_1_2_7_14_2
  doi: 10.1097/01.LAB.0000036874.83540.2B
– ident: e_1_2_7_38_2
  doi: 10.1046/j.1523-1747.2000.00041.x
– ident: e_1_2_7_72_2
  doi: 10.1016/j.jdermsci.2008.12.011
– ident: e_1_2_7_74_2
  doi: 10.1016/j.jaci.2009.07.040
– ident: e_1_2_7_22_2
  doi: 10.1016/j.jaci.2011.01.031
– ident: e_1_2_7_54_2
  doi: 10.1189/JLB.0109046
– ident: e_1_2_7_64_2
  doi: 10.1097/ACI.0b013e3282ef869e
– ident: e_1_2_7_76_2
  doi: 10.1038/jid.2010.175
– ident: e_1_2_7_85_2
  doi: 10.1080/00015550050500077
– ident: e_1_2_7_32_2
  doi: 10.1016/j.arcmed.2005.07.003
– ident: e_1_2_7_44_2
  doi: 10.4049/jimmunol.181.10.7420
– ident: e_1_2_7_25_2
  doi: 10.2174/156652408785160952
– ident: e_1_2_7_61_2
  doi: 10.2353/ajpath.2007.061067
– ident: e_1_2_7_29_2
  doi: 10.1016/j.bbamem.2008.08.027
– ident: e_1_2_7_48_2
  doi: 10.2202/1544-6115.1027
– ident: e_1_2_7_15_2
  doi: 10.1111/j.1600-0625.2006.00478.x
– ident: e_1_2_7_12_2
  doi: 10.1111/j.1365-2133.2005.06989.x
– ident: e_1_2_7_37_2
  doi: 10.1016/j.jaci.2010.10.018
– ident: e_1_2_7_20_2
  doi: 10.1007/s12016-007-0042-7
– ident: e_1_2_7_83_2
  doi: 10.1159/000250218
– ident: e_1_2_7_24_2
  doi: 10.1038/jid.2011.24
– ident: e_1_2_7_7_2
  doi: 10.1111/j.1365-2133.2009.09582.x
– ident: e_1_2_7_63_2
  doi: 10.1111/j.0022-202X.2005.23935.x
– ident: e_1_2_7_35_2
  doi: 10.1002/path.2200
– ident: e_1_2_7_73_2
  doi: 10.1073/pnas.0706942104
– ident: e_1_2_7_60_2
  doi: 10.1016/j.jaci.2003.08.049
– volume: 118
  start-page: 597
  year: 2008
  ident: e_1_2_7_71_2
  publication-title: J Clin Invest
  contributor:
    fullname: Ma H L
– ident: e_1_2_7_62_2
  doi: 10.1016/j.jaci.2009.09.031
– ident: e_1_2_7_45_2
  doi: 10.1016/j.jaci.2009.03.041
– ident: e_1_2_7_36_2
  doi: 10.1007/s004030100221
– ident: e_1_2_7_52_2
  doi: 10.1111/j.1346-8138.2004.tb00672.x
– ident: e_1_2_7_42_2
  doi: 10.1038/jid.2008.111
– ident: e_1_2_7_66_2
  doi: 10.1111/j.1600-0625.2011.01280.x
– ident: e_1_2_7_11_2
  doi: 10.1038/jid.2010.307
– ident: e_1_2_7_41_2
  doi: 10.1067/mai.2003.1414
SSID ssj0017375
Score 2.4594789
Snippet :  Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by...
Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 104
SubjectTerms Allergic diseases
atopic eczema
Biological and medical sciences
Cadherins - genetics
Cadherins - metabolism
Calpain - genetics
Cathepsin B - genetics
Cathepsin D - genetics
Cathepsin L - genetics
Cell Adhesion Molecules - genetics
Cell Differentiation - genetics
Cell Line
Cells, Cultured
Claudins - genetics
Cytoskeletal Proteins - genetics
Dermatology
Down-Regulation - genetics
epidermal barrier
filaggrin
gamma Catenin - genetics
gamma Catenin - metabolism
Gene Expression - drug effects
Gene Expression - genetics
Humans
IL-17
Immunopathology
Interleukin-17 - pharmacology
Intermediate Filament Proteins - genetics
Intermediate Filament Proteins - metabolism
keratinocytes
Keratinocytes - drug effects
Keratinocytes - metabolism
Medical sciences
Membrane Proteins - genetics
Membrane Proteins - metabolism
Oligonucleotide Array Sequence Analysis
Phosphoproteins - genetics
Phosphoproteins - metabolism
S100 Proteins - genetics
Skin allergic diseases. Stinging insect allergies
Up-Regulation - genetics
Zonula Occludens-1 Protein
Zonula Occludens-2 Protein
Title IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion
URI https://api.istex.fr/ark:/67375/WNG-8ZM2TW8D-6/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-0625.2011.01412.x
https://www.ncbi.nlm.nih.gov/pubmed/22229441
https://search.proquest.com/docview/1753471420
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQkRAXKN-hUBkJccsqduI4OVZsS0FsD6hVV1wsOxkvq0VetB_Swqk_gd_IL2EmyS4E9YAQlyiK7CgZz9hv7Odnxl56pzRIiYHkyjTOdJrHpbRJLLxM89pZAE27kUdn-elF9m6sxh3_ifbCtPoQuwk3ioymv6YAt27ZD_KcdkUjgO-UOEUm5IDwpEg1sbuGH3ZKUkKnjeZuUmICnetE9Uk9176oN1LdJKNviDlpl2g83556cR0s7aPcZpg6uctm2x9s2SmzwXrlBtW3P7Qf_48F9tmdDs3yo9b97rEbEO6zW6Nuvf4BC2_f_7j6LjSvMdlftMfew5L76Wc7mSymgdtQc9tSSviM9J2nYV59XQGHTcfQDXzu-YR6ZG47V4Ka0_Qxp0UHYtFyW38CKvqQXZwcn78-jbsTHuIKkaOMU7CuJEmxKpO-QG9KFBCtFWSN46RSPrc1epO0WvvM1aBTKIWrsaxHHFdW6SO2F-YBnjBeWky9isyKwiu8VlZKl0ApC-8yzCkhYmLbmuZLK-RhfkuA0JCGDGnIkKYxpNlE7FXT7LsKdjEjIpxW5vLsjSk-juT5ZTE0ecQOe36xq4AJm8ZvUBF7sXUUg_FL9rEB5uulIaVUBAiZTCL2uPWgX7XpsHXEqxHLGz_46w83x-Mh3T3914oH7DY-li09_RnbWy3W8BzR18odNnH1E7jfIOs
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwEB6hXQm48GYJj8VIiFuqxHk4OSK6SxfaHlBXW3Gx7GRcqq5S1IdUOPET-I38EmaStFC0B4S4RDnYkTOZsb9xPn8D8NLZRKGUFEg2j_xYRamfSxP4oZNRWlqDqPg08mCY9s7jd-Nk3JYD4rMwjT7EbsONI6OerznAeUN6P8pTPhZNCL6V4gzjUHYIUB5S9Edcx6H7YaclFaqoVt0NckqhUxUk-7SeK5-0t1Ydstk3zJ00SzKfa-peXAVM93FuvVCd3obL7Ss2_JRZZ72yneLrH-qP_8kGd-BWC2jF68YD78I1rO7B9UH7y_4-VGf9H9--h0qUlO8vmsr3uBRuemkmk8W0EqYqhWlYJWLGEs_Tal58WaHATUvSrcTciQlPysK03oSl4B1kwf8dmEgrTPkJuekDOD89Gb3p-W2RB78g8Cj9CI3NWVWsiKXLyKGCBJnZirKkpTJJXGpKcihplHKxLVFFmIe2pLaOoFxeRA_hoJpX-AhEbij7ymITZi6ha2GktAHmMnM2prQSPQi3n1N_brQ89G85EBlSsyE1G1LXhtQbD17V333XwSxmzIVTib4YvtXZx4EcXWRdnXpwvOcYuw6UsykaQ-LBi62naAphto-pcL5eahZLJYwQy8CDo8aFfvXmeusEWT1Ia0f464Hrk3GX7x7_a8fncKM3GvR1_2z4_gncpCayYas_hYPVYo3PCIyt7HEdZD8BujElAw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwEB6hXWnFhfcjPBYjIW6pEieOkyOiW3ZhWyG0q624WHZsl6ooXfUhFU78BH4jv4SZJC0E7QEhLlEOduSMZ-xv7M-fAV54I6TjHAPJFEmYyiQLC66jMPY8yazRzkk6jTwcZcfn6duxGLf8JzoL0-hD7BbcKDLq8ZoC_NL6bpBndCoaAXyrxBmnMe8hntxPMwTCBJA-7KSkYpnUortRgRl0JiPRZfVc-aXOVLVPVt8QdVIv0Xq-ufbiKlzahbn1PDW4CbPtHzb0lFlvvTK98usf4o__xwS34EYLZ9mrxv9uwzVX3YGDYbthfxeqk9Mf377HklnM9hfNvfduyfz0s55MFtOK6coy3XBK2IwEnqfVvPyycsxtWopuxeaeTWhIZrr1JWcZrR8z2nUgGi3T9pOjovfgfHB09vo4bK94CEuEjjxMnDYFaYqVKfc5ulMkHPFaHbc4UQrhM23RnbiW0qfGOpm4IjYWy3oEckWZ3Ie9al65h8AKjblXnuo49wKfpebcRK7guTcpJpUugHjbm-qyUfJQv2VAaEhFhlRkSFUbUm0CeFl3-66CXsyICSeFuhi9UfnHIT-7yPsqC-Cw4xe7CpixSWyDCOD51lEUBjDZR1duvl4qkkpFhJDyKIAHjQf9qk23rSNgDSCr_eCvG66Oxn16e_SvFZ_Bwfv-QJ2ejN49hutYgjdU9Sewt1qs3VNEYitzWIfYTyCpI7I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-17+downregulates+filaggrin+and+affects+keratinocyte+expression+of+genes+associated+with+cellular+adhesion&rft.jtitle=Experimental+dermatology&rft.au=Gutowska-Owsiak%2C+Danuta&rft.au=Schaupp%2C+Anna+L.&rft.au=Salimi%2C+Maryam&rft.au=Selvakumar%2C+Tharini+A.&rft.date=2012-02-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0906-6705&rft.eissn=1600-0625&rft.volume=21&rft.issue=2&rft.spage=104&rft.epage=110&rft_id=info:doi/10.1111%2Fj.1600-0625.2011.01412.x&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_8ZM2TW8D_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0906-6705&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0906-6705&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0906-6705&client=summon